These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 7535773)

  • 1. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
    VanderKuur J; Allevato G; Billestrup N; Norstedt G; Carter-Su C
    J Biol Chem; 1995 Mar; 270(13):7587-93. PubMed ID: 7535773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
    Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor.
    VanderKuur JA; Wang X; Zhang L; Allevato G; Billestrup N; Carter-Su C
    J Biol Chem; 1995 Sep; 270(37):21738-44. PubMed ID: 7545168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase.
    VanderKuur JA; Wang X; Zhang L; Campbell GS; Allevato G; Billestrup N; Norstedt G; Carter-Su C
    J Biol Chem; 1994 Aug; 269(34):21709-17. PubMed ID: 8063815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
    Thirone AC; Carvalho CR; Saad MJ
    Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
    Stofega MR; Herrington J; Billestrup N; Carter-Su C
    Mol Endocrinol; 2000 Sep; 14(9):1338-50. PubMed ID: 10976913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.
    Schlaepfer DD; Jones KC; Hunter T
    Mol Cell Biol; 1998 May; 18(5):2571-85. PubMed ID: 9566877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling.
    Rui L; Mathews LS; Hotta K; Gustafson TA; Carter-Su C
    Mol Cell Biol; 1997 Nov; 17(11):6633-44. PubMed ID: 9343427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin.
    Pruett W; Yuan Y; Rose E; Batzer AG; Harada N; Skolnik EY
    Mol Cell Biol; 1995 Mar; 15(3):1778-85. PubMed ID: 7862167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression.
    Yamauchi T; Ueki K; Tobe K; Tamemoto H; Sekine N; Wada M; Honjo M; Takahashi M; Takahashi T; Hirai H; Tsushima T; Akanuma Y; Fujita T; Komuro I; Yazaki Y; Kadowaki T
    Endocr J; 1998 Apr; 45 Suppl():S27-31. PubMed ID: 9790226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.
    Kim SO; Jiang J; Yi W; Feng GS; Frank SJ
    J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1.
    Argetsinger LS; Hsu GW; Myers MG; Billestrup N; White MF; Carter-Su C
    J Biol Chem; 1995 Jun; 270(24):14685-92. PubMed ID: 7782332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.
    Stofega MR; Argetsinger LS; Wang H; Ullrich A; Carter-Su C
    J Biol Chem; 2000 Sep; 275(36):28222-9. PubMed ID: 10842184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation.
    Vanderkuur JA; Butch ER; Waters SB; Pessin JE; Guan KL; Carter-Su C
    Endocrinology; 1997 Oct; 138(10):4301-7. PubMed ID: 9322943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone.
    Carter-Su C; Rui L; Stofega MR
    Recent Prog Horm Res; 2000; 55():293-311. PubMed ID: 11036942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for Grb2-associated binder-1 in growth hormone signaling.
    Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
    Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
    Rui L; Gunter DR; Herrington J; Carter-Su C
    Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors.
    Gong TW; Meyer DJ; Liao J; Hodge CL; Campbell GS; Wang X; Billestrup N; Carter-Su C; Schwartz J
    Endocrinology; 1998 Apr; 139(4):1863-71. PubMed ID: 9528972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.